Koninklijke Philips N.V. (NYSE:PHG) has reportedly taken legal action against SoClean to allocate a portion of the recent $1.1 billion settlement concerning alleged injuries caused by Philips’ ...
Litigation between companies in the med-tech space often revolves around patents, but the ongoing series of lawsuits between Philips Respironics Inc. and Soclean Inc. are directed toward the ...
PETERBOROUGH, N.H., Oct. 12, 2021 /CNW/ -- SoClean Inc. today announced that it has filed a federal lawsuit in the United States District Court for the District of Massachusetts against Philips, the ...
Amsterdam, the Netherlands – Royal Philips’ (NYSE: PHG, AEX: PHIA) subsidiary, Philips Respironics, today provided an update on the remediation status in the US of the ongoing recall of certain sleep ...
The FDA posted an alert April 13 over Philips Respironics’ website’s claim of shipping 2.46 million “new replacement devices and repair kits” after a summer 2021 recall involving millions of ...
Continuous positive airway pressure (CPAP) devices made by Philips Respironics Inc. are still presumed by the U.S. FDA and other regulators to present a health hazard to patients, but the company’s ...
1) Excluding provisions charged to sales of EUR 174 million in Q4 2023 mainly in connection with the Respironics consent decree. Roy Jakobs, CEO of Royal Philips: “Our strong results in 2023 were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results